A gene expression-based immune signature for lung adenocarcinoma prognosis

ConclusionsThe identified DEG features may serve as potential biomarkers for prognosis prediction of LUAD patients and immunotherapy. Based on that assumption, we identified a gene expression-based immune signature for lung adenocarcinoma prognosis.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research